title: Experiences with fetomaternal alloimmune thrombocytopenia in the Netherlands over a 2-year period.
authors.forename: V M L
authors.initials: VM
authors.lastname: Serrarens-Janssen
authors.forename: E A P
authors.initials: EA
authors.lastname: Steegers
authors.forename: A
authors.initials: A
authors.lastname: van den Bos
authors.forename: A F J
authors.initials: AF
authors.lastname: van Heijst
authors.forename: Rodrigues
authors.initials: R
authors.lastname: Pereira
authors.forename: B A
authors.initials: BA
authors.lastname: Semmekrot
mesh_terms: D000328:Adult; D016824:Antigens, Human Platelet / Q000276:immunology*; D005260:Female; D005865:Gestational Age; D006801:Humans; D007112:Immunity, Maternally-Acquired; D015994:Incidence; D007231:Infant, Newborn; D007519:Isoantigens / Q000276:immunology*; D008431:Maternal-Fetal Exchange / Q000276:immunology; D009426:Netherlands / Q000453:epidemiology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D011256:Pregnancy Outcome; D012189:Retrospective Studies; D018570:Risk Assessment; D013921:Thrombocytopenia / Q000151:congenital / Q000453:epidemiology / Q000276:immunology*
chemical_list: D016824:Antigens, Human Platelet; D007519:Isoantigens